More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

There are wonders of the visual world—this week, dive into the hidden beauty of the plants that keep us alive, the less ...

Why BofA worries about Hims & Hers. Hims & Hers stock has been a mega-outperformer for investors, growing more than 600% over ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Short sellers, who bet on stock prices falling, have had a tough start to 2025. In fact, they have lost a staggering $73 billion in the U.S.

This is the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

There are wonders of the visual world—this week, dive into the hidden beauty of the plants that keep us alive, the less ...

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...

U.S. stocks DJIA SPX COMP have opened lower, with Treasury yields BX:TMUBMUSD10Y BX:TMUBMUSD02Y slipping. Gold (GC00) hit a fresh record, while the dollar DXY is lower.

BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 ...